Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells.

Authors:
Address: Department of Cardiology, Center for Heart Failure Research, CARIM, Maastricht University, The Netherlands.
Journal:


Publication:

abstract

AIMS:

Thrombospondin-2 (TSP-2) modulates matrix integrity and myocyte survival in the hypertensive or ageing heart. Whether TSP-2 may affect cardiac inflammation and injury, in particular during acute viral myocarditis, is completely unknown.

METHODS AND RESULTS:

Therefore, mortality, cardiac inflammation, and function were assessed in TSP-2-null (KO) and wild-type (WT) mice in human Coxsackie virus B3 (CVB3)-induced myocarditis. TSP-2 KO had an increased mortality when compared with WT mice during viral myocarditis. The absence of TSP-2 resulted in increased cardiac inflammation and injury at 14 days, which resulted in depressed systolic function [fractional shortening (FS); 34 ± 2.6 in WT vs. 24 ± 1.8 in KO mice, P< 0.05] and increased cardiac dilatation (end-diastolic dimensions, mm; 3.7 ± 0.09 in WT vs. 4.8 ± 0.06 in KO mice, P< 0.05) 35 days post-infection. Lack of TSP-2 resulted in a decreased activation of the anti-inflammatory T-regulatory cells, as indicated by a lower number of CD25-positive T-cells, and significantly decreased gene expression of regulatory T-cell markers, Foxp3 and CTLA-4. Finally, overexpression of TSP-2 in WT hearts using cardiotropic vectors derived from adeno-associated virus serotype 9 (AAV9) inhibited cardiac inflammation and injury at 14 days and improved cardiac function at 35 days post-CVB3 infection when compared with control AAV9.

CONCLUSION:

TSP-2 has a protective role against cardiac inflammation, injury, and dysfunction in acute viral myocarditis.



Related Articles
Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
Circulation. 2009
Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, D'hooge J, Van der Velden J, Weaver MS, Sage EH, Bornstein P, et al. Circulation. 2009 Oct 20; 120(16):1585-97. Epub 2009 Oct 5.
Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
J Mol Cell Cardiol. 2011
Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JP, D'hooge J, Verheyen FK, Pinto YM, Schroen B, Carmeliet P, et al. J Mol Cell Cardiol. 2011 Sep; 51(3):318-28. Epub 2011 May 23.
Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
J Am Coll Cardiol. 2009
Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
Shi Y, Chen C, Lisewski U, Wrackmeyer U, Radke M, Westermann D, Sauter M, Tschöpe C, Poller W, Klingel K, et al. J Am Coll Cardiol. 2009 Apr 7; 53(14):1219-26.
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Circulation. 2008
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Cheung C, Marchant D, Walker EK, Luo Z, Zhang J, Yanagawa B, Rahmani M, Cox J, Overall C, Senior RM, et al. Circulation. 2008 Mar 25; 117(12):1574-82. Epub 2008 Mar 10.
Review Myocarditis as systemic disease: new perspectives on pathogenesis.
Clin Exp Pharmacol Physiol. 1997
Review Myocarditis as systemic disease: new perspectives on pathogenesis.
Carthy CM, Yang D, Anderson DR, Wilson JE, McManus BM. Clin Exp Pharmacol Physiol. 1997 Dec; 24(12):997-1003.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.